Roderike Pohl, VP Research at Biodel Inc (BIOD), sold 2,339 shares at $18.13 ($42K) on 2008-01-30, disclosed to the SEC on 2008-02-01.
Scheduled sale ($42k) by VP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.56 | 100 | $2K | 4.2% |
| 2 | $17.57 | 50 | $879 | 2.1% |
| 3 | $17.58 | 50 | $879 | 2.1% |
| 4 | $17.59 | 50 | $880 | 2.1% |
| 5 | $17.60 | 50 | $880 | 2.1% |
| 6 | $17.61 | 50 |
| $881 |
| 2.1% |
| 7 | $17.62 | 50 | $881 | 2.1% |
| 8 | $17.63 | 50 | $882 | 2.1% |
| 9 | $17.65 | 50 | $882 | 2.1% |
| 10 | $17.66 | 50 | $883 | 2.1% |
| 11 | $17.67 | 50 | $884 | 2.1% |
| 12 | $17.68 | 46 | $813 | 2.0% |
| 13 | $17.69 | 100 | $2K | 4.2% |
| 14 | $17.71 | 50 | $886 | 2.1% |
| 15 | $17.72 | 50 | $886 | 2.1% |
| 16 | $17.76 | 5 | $89 | 0.2% |
| 17 | $17.77 | 50 | $889 | 2.1% |
| 18 | $17.78 | 25 | $445 | 1.1% |
| 19 | $17.79 | 45 | $801 | 1.9% |
| 20 | $17.80 | 250 | $4K | 10.7% |
| 21 | $17.82 | 25 | $446 | 1.1% |
| 22 | $17.83 | 54 | $963 | 2.3% |
| 23 | $17.87 | 50 | $894 | 2.1% |
| 24 | $17.90 | 50 | $895 | 2.1% |
| 25 | $17.97 | 50 | $899 | 2.2% |
| 26 | $18.00 | 689 | $12K | 29.7% |
| 27 | $18.04 | 50 | $902 | 2.2% |
| 28 | $18.07 | 50 | $904 | 2.2% |
| 29 | $18.09 | 50 | $905 | 2.2% |
| 30 | $18.13 | 50 | $907 | 2.2% |
| Total | $17.83 avg | 2,339 | $42K | 100% |
| Filing → |
| BIOD | SELL | 2008-01-31 | $20K | — | Filing → |
| BIOD | SELL | 2008-01-31 | $36K | — | Filing → |
| BIOD | SELL | 2008-01-28 | $54K | — | Filing → |